Breast Cancer News From Medical News TodayLatest Breast Cancer News From Medical News Today.Breast Cancer Researchers Find Potential In New Combination Of Existing Cheaper Drugs- August 13, 2008 Scientists in the UK and Finland have discovered that a new combination of the chemotherapy drug doxorubicin and the bone-protecting drug zoledronic acid, both of which are considerably cheaper than herceptin, stopped breast cancer tumors growing in mice. Experts suggest that since both drugs are already in use, and if the combination proves effective and safe in human clinical trials, it should not take as long for it to be available as a new treatment for patients.http://www.medicalnewstoday.com/articles/118157.php Risk Assessment Plays Key Role In Long-Term Treatment Of Breast Cancer- August 13, 2008 Breast cancer patients and their physicians may make more informed, long-term treatment decisions using risk assessment strategies to help determine probability of recurrence, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reported in the Aug. 12 online issue of the Journal of the National Cancer Institute.http://www.medicalnewstoday.com/articles/118082.php Risk Assessment Plays Key Role In Long Term Treatment Of Breast Cancer- August 13, 2008 Breast cancer patients and their physicians may make more informed, long-term treatment decisions using risk assessment strategies to help determine probability of recurrence, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reported in the Aug. 12 online issue of the Journal of the National Cancer Institute.http://www.medicalnewstoday.com/articles/118068.php Celebrities Show True Colours In Charity Fashion Campaign, Breakthrough UK- August 13, 2008 Famous names from the fashion, television, radio and music industries have come together to back Fashion Targets Breast Cancer (FTBC) UK in an advertising campaign which subtly plays on the topic of celebrity charity endorsement. Natalie Imbruglia, Anna Friel, Alan Carr, Edith Bowman and Twiggy have been shot by acclaimed photographer Rankin wearing their FTBC T-shirts with pride for the campaign from leading charity Breakthrough Breast Cancer which aims to raise 1m.http://www.medicalnewstoday.com/articles/118050.php Breast Cancer Risk Of Relapse Is Not Negligible Say Researchers- August 13, 2008 US researchers estimated that the risk of relapse for breast cancer patients who were cancer-free for five years after systemic therapy (chemotherapy, hormone therapy, or both, as well as surgery) was not negligible although it was probably lower than many people realized.http://www.medicalnewstoday.com/articles/118078.php Peregrine Pharmaceuticals Doses First Patient In Phase II Trial Of Bavituximab In Patients With Advanced Breast Cancer- August 12, 2008 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) announced that patient screening and dosing has begun in a Phase II trial designed to evaluate the safety and efficacy of bavituximab in combination with chemotherapy in patients with advanced breast cancer.http://www.medicalnewstoday.com/articles/117911.php American Airlines, American Eagle And Susan G. Komen For The Cure Announce Expanded Partnership, Unveil Two Pink-ribbon Aircraft- August 12, 2008 American Airlines, the world's largest airline, and Susan G. Komen for the Cure, the world's largest breast cancer organization, announced an expanded partnership with the unveiling of two specially co-branded aircraft, an American Airlines Boeing 757 and an American Eagle Embraer 145, each incorporating the renowned vivid pink-ribbon motif.http://www.medicalnewstoday.com/articles/117892.php Geron Initiates Clinical Trial Of GRN163L In Combination With Paclitaxel And Bevacizumab In Patients With Breast Cancer- August 11, 2008 Geron Corporation (Nasdaq: GERN) announced the enrollment of the first patient in a clinical trial of its telomerase inhibitor drug, GRN163L, in locally recurrent or metastatic breast cancer. The primary objective of the Phase III, dose escalation study is to determine the safety, maximum tolerated dose (MTD) and objective response rate of GRN163L when administered intravenously in combination with a paclitaxelbevacizumab regimen in this patient population.http://www.medicalnewstoday.com/articles/117733.php Beyond PTEN: Alternate Genes Linked To Breast, Thyroid And Kidney Cancer Predisposition- August 8, 2008 A new discovery may lead to more effective screening and treatment for patients with a difficult to recognize syndrome characterized by tumor-like growths and a high risk of developing specific cancers. The research, published by Cell Press in the August 7 issue of the American Journal of Human Genetics, is the first in over thirteen years to identify an alternate susceptibility gene for Cowden syndrome (CS) and related disorders.http://www.medicalnewstoday.com/articles/117660.php First Step Towards Switching Off Breast Cancer And Leukaemia- August 8, 2008 Australian scientists have identified a way to 'switch off' a molecule, a key player in the molecular processes that trigger breast cancer and certain forms of leukaemia. The molecule, known as Gab2, operates downstream of a major breast cancer oncogene, HER2, the target of the drug Herceptin.http://www.medicalnewstoday.com/articles/117642.php |